Interrad Medical, Inc.
LGB is acting as the European placement agent in the $7 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com).
The company has developed a platform technology for the stabilisation of catheters using a sub-cutaneous anchor. The UK's NICE issued guidance in favour of the use of its lead product, SecurAcath, in June. More than $5 million of notes have been issued so far.